Cigna Corporation (CI)
USD 282.41
(6.33%)
USD 282.41
(6.33%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 5.16 Billion USD | -22.97% |
| 2022 | 6.7 Billion USD | 24.84% |
| 2021 | 5.37 Billion USD | -36.51% |
| 2020 | 8.45 Billion USD | 65.71% |
| 2019 | 5.1 Billion USD | 93.55% |
| 2018 | 2.63 Billion USD | 17.88% |
| 2017 | 2.23 Billion USD | 19.82% |
| 2016 | 1.86 Billion USD | -10.84% |
| 2015 | 2.09 Billion USD | -0.38% |
| 2014 | 2.1 Billion USD | 42.41% |
| 2013 | 1.47 Billion USD | -9.06% |
| 2012 | 1.62 Billion USD | 22.31% |
| 2011 | 1.32 Billion USD | -1.34% |
| 2010 | 1.34 Billion USD | 3.3% |
| 2009 | 1.3 Billion USD | 345.89% |
| 2008 | 292 Million USD | -73.81% |
| 2007 | 1.11 Billion USD | -3.46% |
| 2006 | 1.15 Billion USD | -28.92% |
| 2005 | 1.62 Billion USD | 13.0% |
| 2004 | 1.43 Billion USD | 115.27% |
| 2003 | 668 Million USD | 267.84% |
| 2002 | -398 Million USD | -140.24% |
| 2001 | 989 Million USD | 0.2% |
| 2000 | 987 Million USD | -44.36% |
| 1999 | 1.77 Billion USD | 37.31% |
| 1998 | 1.29 Billion USD | 18.97% |
| 1997 | 1.08 Billion USD | 2.84% |
| 1996 | 1.05 Billion USD | 400.47% |
| 1995 | 211 Million USD | -61.91% |
| 1994 | 554 Million USD | 136.75% |
| 1993 | 234 Million USD | -24.76% |
| 1992 | 311 Million USD | -30.73% |
| 1991 | 449 Million USD | 36.06% |
| 1990 | 330 Million USD | -41.28% |
| 1989 | 562 Million USD | 19.02% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -277 Million USD | -126.92% |
| 2024 Q2 | 1.54 Billion USD | 658.84% |
| 2024 Q3 | 86 Million USD | -52.26% |
| 2023 Q2 | 1.46 Billion USD | 15.23% |
| 2023 Q3 | 41 Million USD | -97.19% |
| 2023 Q1 | 1.26 Billion USD | 8.38% |
| 2023 FY | 5.16 Billion USD | -22.97% |
| 2023 Q4 | 1.02 Billion USD | 2409.76% |
| 2022 FY | 6.7 Billion USD | 24.84% |
| 2022 Q1 | 1.19 Billion USD | 7.26% |
| 2022 Q2 | 1.55 Billion USD | 30.08% |
| 2022 Q3 | 2.75 Billion USD | 77.07% |
| 2022 Q4 | 1.16 Billion USD | -57.6% |
| 2021 Q1 | 1.16 Billion USD | -71.92% |
| 2021 Q2 | 1.46 Billion USD | 26.36% |
| 2021 Q4 | 1.11 Billion USD | -31.15% |
| 2021 Q3 | 1.62 Billion USD | 10.5% |
| 2021 FY | 5.37 Billion USD | -36.51% |
| 2020 Q4 | 4.13 Billion USD | 197.91% |
| 2020 Q2 | 1.75 Billion USD | 48.52% |
| 2020 Q1 | 1.18 Billion USD | 20.88% |
| 2020 FY | 8.45 Billion USD | 65.71% |
| 2020 Q3 | 1.38 Billion USD | -20.87% |
| 2019 FY | 5.1 Billion USD | 93.55% |
| 2019 Q4 | 977 Million USD | -27.68% |
| 2019 Q1 | 1.36 Billion USD | 850.0% |
| 2019 Q3 | 1.35 Billion USD | -4.05% |
| 2019 Q2 | 1.4 Billion USD | 2.92% |
| 2018 Q4 | 144 Million USD | -81.35% |
| 2018 FY | 2.63 Billion USD | 17.88% |
| 2018 Q3 | 772 Million USD | -4.22% |
| 2018 Q2 | 806 Million USD | -11.91% |
| 2018 Q1 | 915 Million USD | 243.98% |
| 2017 Q2 | 813 Million USD | 35.95% |
| 2017 Q4 | 266 Million USD | -52.5% |
| 2017 Q3 | 560 Million USD | -31.12% |
| 2017 FY | 2.23 Billion USD | 19.82% |
| 2017 Q1 | 598 Million USD | 56.54% |
| 2016 Q3 | 456 Million USD | -10.59% |
| 2016 Q1 | 519 Million USD | 21.83% |
| 2016 FY | 1.86 Billion USD | -10.84% |
| 2016 Q2 | 510 Million USD | -1.73% |
| 2016 Q4 | 382 Million USD | -16.23% |
| 2015 FY | 2.09 Billion USD | -0.38% |
| 2015 Q1 | 533 Million USD | 14.13% |
| 2015 Q2 | 588 Million USD | 10.32% |
| 2015 Q3 | 547 Million USD | -6.97% |
| 2015 Q4 | 426 Million USD | -22.12% |
| 2014 FY | 2.1 Billion USD | 42.41% |
| 2014 Q4 | 467 Million USD | -12.55% |
| 2014 Q2 | 573 Million USD | 8.52% |
| 2014 Q1 | 528 Million USD | 46.26% |
| 2014 Q3 | 534 Million USD | -6.81% |
| 2013 Q2 | 505 Million USD | 785.96% |
| 2013 FY | 1.47 Billion USD | -9.06% |
| 2013 Q4 | 361 Million USD | -34.72% |
| 2013 Q3 | 553 Million USD | 9.5% |
| 2013 Q1 | 57 Million USD | -85.96% |
| 2012 Q2 | 380 Million USD | 2.43% |
| 2012 Q1 | 371 Million USD | 27.93% |
| 2012 FY | 1.62 Billion USD | 22.31% |
| 2012 Q4 | 406 Million USD | -12.88% |
| 2012 Q3 | 466 Million USD | 22.63% |
| 2011 FY | 1.32 Billion USD | -1.34% |
| 2011 Q3 | 183 Million USD | -53.2% |
| 2011 Q1 | 413 Million USD | -10.41% |
| 2011 Q2 | 391 Million USD | -5.33% |
| 2011 Q4 | 290 Million USD | 58.47% |
| 2010 Q3 | 307 Million USD | 4.42% |
| 2010 Q2 | 294 Million USD | 3.89% |
| 2010 Q1 | 283 Million USD | -14.24% |
| 2010 FY | 1.34 Billion USD | 3.3% |
| 2010 Q4 | 461 Million USD | 50.16% |
| 2009 Q1 | 208 Million USD | 199.52% |
| 2009 Q2 | 435 Million USD | 109.13% |
| 2009 Q3 | 329 Million USD | -24.37% |
| 2009 Q4 | 330 Million USD | 0.3% |
| 2009 FY | 1.3 Billion USD | 345.89% |
| 2008 Q4 | -209 Million USD | -222.22% |
| 2008 Q2 | 272 Million USD | 368.97% |
| 2008 Q1 | 58 Million USD | -77.95% |
| 2008 FY | 292 Million USD | -73.81% |
| 2008 Q3 | 171 Million USD | -37.13% |
| 2007 FY | 1.11 Billion USD | -3.46% |
| 2007 Q4 | 263 Million USD | -27.95% |
| 2007 Q3 | 365 Million USD | 84.34% |
| 2007 Q2 | 198 Million USD | -31.49% |
| 2007 Q1 | 289 Million USD | 24.57% |
| 2006 Q1 | 352 Million USD | 67.62% |
| 2006 FY | 1.15 Billion USD | -28.92% |
| 2006 Q4 | 232 Million USD | -22.15% |
| 2006 Q3 | 298 Million USD | 9.16% |
| 2006 Q2 | 273 Million USD | -22.44% |
| 2005 Q3 | 259 Million USD | -64.03% |
| 2005 Q1 | 436 Million USD | -16.95% |
| 2005 Q2 | 720 Million USD | 65.14% |
| 2005 FY | 1.62 Billion USD | 13.0% |
| 2005 Q4 | 210 Million USD | -18.92% |
| 2004 Q3 | 308 Million USD | -38.89% |
| 2004 FY | 1.43 Billion USD | 115.27% |
| 2004 Q1 | 68 Million USD | -76.55% |
| 2004 Q4 | 525 Million USD | 70.45% |
| 2004 Q2 | 504 Million USD | 641.18% |
| 2003 Q1 | 236 Million USD | 402.13% |
| 2003 Q4 | 290 Million USD | 48.72% |
| 2003 Q3 | 195 Million USD | 467.92% |
| 2003 FY | 668 Million USD | 267.84% |
| 2003 Q2 | -53 Million USD | -122.46% |
| 2002 FY | -398 Million USD | -140.24% |
| 2002 Q1 | 218 Million USD | 14.14% |
| 2002 Q2 | 214 Million USD | -1.83% |
| 2002 Q3 | -877 Million USD | -509.81% |
| 2002 Q4 | 47 Million USD | 105.36% |
| 2001 Q4 | 191 Million USD | -29.26% |
| 2001 FY | 989 Million USD | 0.2% |
| 2001 Q1 | 276 Million USD | -0.36% |
| 2001 Q3 | 270 Million USD | 7.14% |
| 2001 Q2 | 252 Million USD | -8.7% |
| 2000 Q4 | 277 Million USD | -0.36% |
| 2000 Q1 | 271 Million USD | -7.19% |
| 2000 FY | 987 Million USD | -44.36% |
| 2000 Q2 | 161 Million USD | -40.59% |
| 2000 Q3 | 278 Million USD | 72.67% |
| 1999 Q1 | 188 Million USD | -21.01% |
| 1999 Q4 | 292 Million USD | -72.5% |
| 1999 Q3 | 1.06 Billion USD | 357.76% |
| 1999 Q2 | 232 Million USD | 23.4% |
| 1999 FY | 1.77 Billion USD | 37.31% |
| 1998 FY | 1.29 Billion USD | 18.97% |
| 1998 Q3 | 251 Million USD | -18.51% |
| 1998 Q4 | 238 Million USD | -5.18% |
| 1998 Q2 | 308 Million USD | -37.78% |
| 1998 Q1 | 495 Million USD | 106.25% |
| 1997 Q4 | 240 Million USD | -13.98% |
| 1997 Q2 | 279 Million USD | -3.13% |
| 1997 Q1 | 288 Million USD | -5.88% |
| 1997 FY | 1.08 Billion USD | 2.84% |
| 1997 Q3 | 279 Million USD | 0.0% |
| 1996 Q4 | 306 Million USD | 8.9% |
| 1996 Q2 | 231 Million USD | -2.94% |
| 1996 FY | 1.05 Billion USD | 400.47% |
| 1996 Q1 | 238 Million USD | -15.6% |
| 1996 Q3 | 281 Million USD | 21.65% |
| 1995 Q1 | 290 Million USD | 59.34% |
| 1995 Q4 | 282 Million USD | 149.82% |
| 1995 Q3 | -566 Million USD | -376.1% |
| 1995 FY | 211 Million USD | -61.91% |
| 1995 Q2 | 205 Million USD | -29.31% |
| 1994 FY | 554 Million USD | 136.75% |
| 1994 Q4 | 182 Million USD | 47.97% |
| 1994 Q3 | 123 Million USD | -8.89% |
| 1994 Q2 | 135 Million USD | 18.42% |
| 1994 Q1 | 114 Million USD | -41.24% |
| 1993 Q2 | 88 Million USD | 91.3% |
| 1993 Q1 | 46 Million USD | 84.0% |
| 1993 FY | 234 Million USD | -24.76% |
| 1993 Q3 | -94 Million USD | -206.82% |
| 1993 Q4 | 194 Million USD | 306.38% |
| 1992 FY | 311 Million USD | -30.73% |
| 1992 Q2 | 125 Million USD | 17.92% |
| 1992 Q4 | 25 Million USD | -54.55% |
| 1992 Q3 | 55 Million USD | -56.0% |
| 1992 Q1 | 106 Million USD | -1.85% |
| 1991 Q1 | 48 Million USD | -59.66% |
| 1991 Q3 | 123 Million USD | -27.65% |
| 1991 Q4 | 108 Million USD | -12.2% |
| 1991 Q2 | 170 Million USD | 254.17% |
| 1991 FY | 449 Million USD | 36.06% |
| 1990 Q1 | 42 Million USD | -78.14% |
| 1990 Q4 | 119 Million USD | 981.82% |
| 1990 Q3 | 11 Million USD | -93.04% |
| 1990 Q2 | 158 Million USD | 276.19% |
| 1990 FY | 330 Million USD | -41.28% |
| 1989 Q1 | 85.5 Million USD | -39.75% |
| 1989 Q4 | 192.1 Million USD | 36.82% |
| 1989 Q2 | 144 Million USD | 68.42% |
| 1989 Q3 | 140.4 Million USD | -2.5% |
| 1989 FY | 562 Million USD | 19.02% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Centene Corporation | 2.7 Billion USD | -91.118% |
| CVS Health Corporation | 8.34 Billion USD | 38.111% |
| Elevance Health Inc. | 5.98 Billion USD | 13.746% |
| Humana Inc. | 2.48 Billion USD | -107.473% |
| Molina Healthcare, Inc. | 1.09 Billion USD | -373.327% |
| Oscar Health, Inc. | -270.72 Million USD | 2007.45% |
| UnitedHealth Group Incorporated | 22.38 Billion USD | 76.927% |